Clinical utility of HPV genotyping

This publication has 38 references indexed in Scilit:

• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006
• Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas
  Journal of Clinical Microbiology, 2006
• Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
  JNCI Journal of the National Cancer Institute, 2006
• Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence
  Gynecologic Oncology, 2005
• The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
  JNCI Journal of the National Cancer Institute, 2005
• Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
  JNCI Journal of the National Cancer Institute, 2005
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
  Obstetrics & Gynecology, 2004
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
  British Journal of Cancer, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
  British Journal of Cancer, 2003